Wockhardt Limited
WOCKPHARMA
Helyezés a részvények között
#4494
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Részvényárfolyam
$21.04
Utolsó szinkronizálás: 2026-10-19
Piaci kapitalizáció
$3.42B
Változás (1 nap)
-2.39%
Változás (1 év)
38.07%
Ország
IN
Kereskedés Wockhardt Limited (WOCKPHARMA)
Kategória
Healthcare
EPS Wockhardt Limited (WOCKPHARMA) részvényre
EPS June 2026 dátummal, TTM: $0.28
Wockhardt Limited legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) $0.28. 2024 végén a vállalat EPS mutatója $-0.39 volt, csökkenés a 2023 év EPS értékéhez, amely $-0.47 volt.
Wockhardt Limited EPS története 2004 és 2026 között
EPS minden év végén
| Év | EPS | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $0.28 | -794.25% |
| 2025 | $-0.04 | -90.88% |
| 2024 | $-0.39 | -18.45% |
| 2023 | $-0.47 | 77.08% |
| 2022 | $-0.27 | -21.59% |
| 2021 | $-0.34 | 73.20% |
| 2020 | $-0.20 | -47.92% |
| 2019 | $-0.38 | -55.39% |
| 2018 | $-0.84 | 209.37% |
| 2017 | $-0.27 | -179.67% |
| 2016 | $0.34 | -41.89% |
| 2015 | $0.59 | -53.86% |
| 2014 | $1.28 | -51.83% |
| 2013 | $2.65 | 366.49% |
| 2012 | $0.57 | 232.75% |
| 2011 | $0.17 | -109.11% |
| 2010 | $-1.88 | 678.46% |
| 2008 | $-0.24 | -129.20% |
| 2007 | $0.83 | 80.04% |
| 2006 | $0.46 | -4.80% |
| 2005 | $0.48 | 16.08% |
| 2004 | $0.41 | 0.00% |
EPS hasonló cégek vagy versenytársak esetén
| Vállalat | EPS | EPS különbség | Ország |
|---|---|---|---|
| $2.41 | 767.84% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.02 | -93.23% |
HK
|
